HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Chul Gu Kim Selected Research

Polypoidal Choroidal Vasculopathy

10/2022Development of subretinal hemorrhage after treatment discontinuation for neovascular age-related macular degeneration and polypoidal choroidal vasculopathy.
11/2021Five-Year Reactivation After Ranibizumab or Aflibercept Treatment for Neovascular Age-Related Macular Degeneration and Polypoidal Choroidal Vasculopathy.
1/2021Long-term outcome of intravitreal anti-vascular endothelial growth factor treatment for pachychoroid neovasculopathy.
8/2020Long-term switching between ranibizumab and aflibercept in neovascular age-related macular degeneration and polypoidal choroidal vasculopathy.
1/2020Long-term Clinical Course after Vitrectomy for Breakthrough Vitreous Hemorrhage Secondary to Neovascular Age-related Macular Degeneration and Polypoidal Choroidal Vasculopathy.
1/2020Intravitreal aflibercept for submacular hemorrhage secondary to neovascular age-related macular degeneration and polypoidal choroidal vasculopathy.
1/2019Visual Prognosis in the Better-seeing Eyes of Patients with Unilateral Polypoidal Choroidal Vasculopathy.
11/2018MORPHOLOGIC FEATURES ASSOCIATED WITH FIBROTIC SCARRING AFTER ANTI-VASCULAR ENDOTHELIAL GROWTH FACTOR THERAPY IN POLYPOIDAL CHOROIDAL VASCULOPATHY.
3/2018Hyperpigmented spots after treatment for submacular hemorrhage secondary to polypoidal choroidal vasculopathy.
1/2018Quantification of retinal changes after resolution of submacular hemorrhage secondary to polypoidal choroidal vasculopathy.
For more, sign up at right for free...

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Chul Gu Kim Research Topics

Disease

24Polypoidal Choroidal Vasculopathy
10/2022 - 04/2012
21Macular Degeneration (Age-Related Maculopathy)
10/2022 - 01/2013
17Hemorrhage
10/2022 - 04/2012
5Macular Edema
06/2018 - 09/2007
4Choroidal Neovascularization
01/2022 - 10/2013
4Vitreous Hemorrhage
01/2020 - 04/2012
4Polyps
08/2016 - 06/2012
3Retinal Detachment (Retinal Detachments)
12/2021 - 10/2013
3Cataract (Cataracts)
06/2018 - 10/2014
2Atrophy
12/2021 - 08/2019
2Disease Progression
01/2020 - 01/2016
2Cicatrix (Scar)
01/2020 - 11/2018
2Retinal Telangiectasis
01/2019 - 08/2016
2Diabetic Retinopathy (Retinopathy, Diabetic)
06/2018 - 01/2016
2Retinal Vein Occlusion
06/2018 - 01/2015
1Retinal Arterial Macroaneurysm
01/2021
1Aneurysm (Aneurysms)
01/2019
1Glaucoma
06/2018
1Intraoperative Complications
06/2018
1Retinal Neovascularization
08/2017
1Epiretinal Membrane (Epiretinal Membranes)
07/2017
1Central Serous Chorioretinopathy
01/2016
1Geographic Atrophy
02/2015
1Arterial Occlusive Diseases (Arterial Occlusive Disease)
10/2013
1Cysts
10/2013
1Hearing Loss (Hearing Impairment)
10/2013
1Susac Syndrome
10/2013
1Scotoma (Scintillating Scotoma)
01/2013
1Capillary Hemangioma
09/2007
1Hemangioma (Angioma)
09/2007

Drug/Important Bio-Agent (IBA)

19Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA
01/2022 - 09/2013
15Ranibizumab (Lucentis)FDA Link
11/2021 - 04/2012
14Retinaldehyde (Retinal)IBA
12/2021 - 09/2007
10afliberceptIBA
11/2021 - 01/2016
7Bevacizumab (Avastin)FDA Link
01/2021 - 06/2012
3Indocyanine Green (Cardio-Green)FDA LinkGeneric
01/2017 - 10/2013
2Endothelial Growth FactorsIBA
07/2017 - 11/2013
2Triamcinolone Acetonide (Azmacort)FDA LinkGeneric
01/2015 - 09/2007
2Fluorescein (Funduscein)FDA LinkGeneric
10/2013 - 10/2013
1Ophthalmic Solutions (Eye Drops)IBA
06/2018
1Therapeutic UsesIBA
03/2013
1Verteporfin (Visudyne)FDA Link
09/2007

Therapy/Procedure

13Injections
08/2019 - 06/2012
12Therapeutics
01/2021 - 03/2013
5Vitrectomy
01/2020 - 04/2012
4Aftercare (After-Treatment)
10/2022 - 01/2016
4Lasers (Laser)
01/2019 - 01/2013
3Light Coagulation
01/2019 - 01/2016
3Intravitreal Injections
06/2018 - 06/2012
1Phacoemulsification
06/2018
1Intraocular Lenses (Intraocular Lens)
10/2014
1Photochemotherapy (Photodynamic Therapy)
09/2007